OncoProTools wants to force breakthroughs in cancer diagnosis and therapy, relying on innovative protease targeting technologies. The consortium’s Corporate Mission is to train nine Doctoral Candidates (DCs) to become future leaders of Research & Innovation (R&I) in patient-centered oncotherapy and diagnostics.
